These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12105146)

  • 1. Role of the alpha1D-adrenergic receptor in the development of salt-induced hypertension.
    Tanoue A; Koba M; Miyawaki S; Koshimizu TA; Hosoda C; Oshikawa S; Tsujimoto G
    Hypertension; 2002 Jul; 40(1):101-6. PubMed ID: 12105146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.
    Hosoda C; Koshimizu TA; Tanoue A; Nasa Y; Oikawa R; Tomabechi T; Fukuda S; Shinoura H; Oshikawa S; Takeo S; Kitamura T; Cotecchia S; Tsujimoto G
    Mol Pharmacol; 2005 Mar; 67(3):912-22. PubMed ID: 15598970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension.
    Makaritsis KP; Handy DE; Johns C; Kobilka B; Gavras I; Gavras H
    Hypertension; 1999 Jan; 33(1):14-7. PubMed ID: 9931075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice.
    Makaritsis KP; Johns C; Gavras I; Gavras H
    Hypertension; 2000 Feb; 35(2):609-13. PubMed ID: 10679505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype.
    Makaritsis KP; Johns C; Gavras I; Altman JD; Handy DE; Bresnahan MR; Gavras H
    Hypertension; 1999 Sep; 34(3):403-7. PubMed ID: 10489385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor.
    Oikawa R; Hosoda C; Nasa Y; Daicho T; Tanoue A; Tsujimoto G; Takagi N; Tanonaka K; Takeo S
    Cardiovasc Res; 2010 Jul; 87(1):187-94. PubMed ID: 20118201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced vascular contractility in alpha1-adrenergic receptor-deficient mice.
    Sanbe A; Tanaka Y; Fujiwara Y; Miyauchi N; Mizutani R; Yamauchi J; Cotecchia S; Koike K; Tsujimoto G; Tanoue A
    Life Sci; 2009 May; 84(21-22):713-8. PubMed ID: 19249315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of behavioral abnormalities in alpha1d-adrenoceptors deficient mice.
    Mishima K; Tanoue A; Tsuda M; Hasebe N; Fukue Y; Egashira N; Takano Y; Kamiya HO; Tsujimoto G; Iwasaki K; Fujiwara M
    Behav Brain Res; 2004 Jul; 152(2):365-73. PubMed ID: 15196805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of α1D -adrenoceptors in vascular wall hypertrophy during angiotensin II-induced hypertension.
    Gallardo-Ortíz IA; Rodríguez-Hernández SN; López-Guerrero JJ; Del Valle-Mondragón L; López-Sánchez P; Touyz RM; Villalobos-Molina R
    Auton Autacoid Pharmacol; 2015 Sep; 35(3):17-31. PubMed ID: 26845248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha 1D-adrenergic receptor modulates cardiovascular and drinking responses to central salt loading in mice.
    Chu CP; Kunitake T; Kato K; Watanabe S; Qiu DL; Tanoue A; Kannan H
    Neurosci Lett; 2004 Feb; 356(1):33-6. PubMed ID: 14746895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains.
    Combe R; Mudgett J; El Fertak L; Champy MF; Ayme-Dietrich E; Petit-Demoulière B; Sorg T; Herault Y; Madwed JB; Monassier L
    PLoS One; 2016; 11(4):e0153472. PubMed ID: 27088730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor inhibits alpha1D-adrenergic receptor expression in vascular smooth muscle cells in vitro and ex vivo.
    Xin X; Yang N; Faber JE
    Mol Pharmacol; 1999 Dec; 56(6):1143-51. PubMed ID: 10570041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.
    Uberti MA; Hague C; Oller H; Minneman KP; Hall RA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):16-23. PubMed ID: 15615865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle.
    Xin X; Yang N; Eckhart AD; Faber JE
    Mol Pharmacol; 1997 May; 51(5):764-75. PubMed ID: 9145914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor.
    Chen Q; Takahashi S; Zhong S; Hosoda C; Zheng HY; Ogushi T; Fujimura T; Ohta N; Tanoue A; Tsujimoto G; Kitamura T
    J Urol; 2005 Jul; 174(1):370-4. PubMed ID: 15947692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.
    Duka I; Kintsurashvili E; Gavras I; Johns C; Bresnahan M; Gavras H
    Circ Res; 2001 Feb; 88(3):275-81. PubMed ID: 11179194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses to noxious stimuli in mice lacking alpha(1d)-adrenergic receptors.
    Harasawa I; Honda K; Tanoue A; Shinoura H; Ishida Y; Okamura H; Murao N; Tsujimoto G; Higa K; Kamiya HO; Takano Y
    Neuroreport; 2003 Oct; 14(14):1857-60. PubMed ID: 14534435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Targeted Alpha 1D-Adrenergic Receptor for Hypertension.
    Li C; Yan X; Wu D; Zhang K; Liang X; Pan Y; Zhou Y; Chen F; Chen X; Yang S; Zhou Z; Wei Y; Liao Y; Qiu Z
    Hypertension; 2019 Dec; 74(6):1551-1562. PubMed ID: 31607175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1- and alpha2-adrenoceptor control of sodium transport reverses in developing hypertension.
    Gesek FA
    Hypertension; 1999 Jan; 33(1 Pt 2):524-9. PubMed ID: 9931159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.